Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during April 2025'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec Limited has submitted a routine compliance report to the stock exchanges under SEBI Regulation 74(5), detailing shares dematerialized during April 2025. Only 1,000 shares belonging to one shareholder (Harish Pejavar) were dematerialized during the month. The total number of shares held in dematerialized form as of April 30, 2025 stood at 6,10,95,525 (approximately 6.11 crore shares), with 5,21,98,335 in NSDL and 88,97,190 in CDSL. The total dematerialized shares increased marginally by 1,000 from 6,10,94,525 on March 31, 2025. The certificate was issued by the company's Registrar and Transfer Agent, Skyline Financial Services Pvt. Ltd.
This is a routine monthly regulatory disclosure with no material impact on shareholders or the stock price. It confirms that almost all of the company's shares are already in dematerialized form, indicating a well-established electronic shareholding structure.